Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
NCT ID: NCT01389206
Last Updated: 2018-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
797 participants
OBSERVATIONAL
2011-06-01
2018-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Upfront Combination Pulmonary Arterial Hypertension Therapy
NCT03809156
Patient Reported Outcomes in Pulmonary Arterial Hypertension
NCT01792622
PAH Exercise Study
NCT06941441
Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
NCT00317486
Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension
NCT03293407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care
Observational study to improve the management of PAH patients through an evidence-based approach aimed at achieving optimal WHO functional class (FC) treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi.
observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Documented diagnosis of PAH (all of the following): i. RHC demonstrating mPAP \> 25 mm Hg and PCWP
≤ 15 and PVR \> 3 ii. FEV 1 \> 50% predicted normal iii. V/Q and/or CT scan excluding the thromboembolic etiology
3. Diagnosis of PAH \< 3 years
4. Need for PAH specific treatment
5. Desire to participate and signs an informed consent
Exclusion Criteria
1. Poor mental function, drug or substance (e.g.,alcohol) abuse, or unstable psychiatric illness, which, in the opinion of the investigator, may interfere with optimal participation in the study
2. Prior participation in this program
3. Patients with pulmonary hypertension classified as group 2 - 5 Updated Clinical Classification of Pulmonary Hypertension (5th World Symposium on PH Modified Classification of PH)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Heart Research Centre
OTHER
Actelion
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vallerie McLaughlin, MD
Role: STUDY_CHAIR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Associates, PC
Birmingham, Alabama, United States
University of South Alabama Medical Center
Mobile, Alabama, United States
Pulmonary Associates
Phoenix, Arizona, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Alliance Medical and Research Center
Fountain Valley, California, United States
Scripps Clinic, Scripps Green Hospital
La Jolla, California, United States
University of Southern California
Los Angeles, California, United States
Paloma Medical Group
San Juan Capistrano, California, United States
Harbor-UCLA Medical Center
Torrance, California, United States
University of Colorado Denver
Aurora, Colorado, United States
South Denver Cardiology Associates PC
Littleton, Colorado, United States
Robert E. Benkert, M.D.P.C.
Wheat Ridge, Colorado, United States
Lung Health & Sleep Enhancement Center, LLC
Newark, Delaware, United States
Bay Area Cardiology Research, P.A.
Brandon, Florida, United States
Bay Area Chest Physicians
Clearwater, Florida, United States
Broward Pulmonary and Sleep Specialists
Fort Lauderdale, Florida, United States
Pulmonary Diseases, Internal Medicine, Critical Care Medicine
Fort Lauderdale, Florida, United States
Mount Sinai Medical Centre - Columbia University - Division of Cardiology
Miami Beach, Florida, United States
Central Florida Pulmonary Group, PA
Orlando, Florida, United States
Lung Associates of Sarasota
Sarasota, Florida, United States
Cleveland Clinic Florida
Weston, Florida, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Unity Point Health Pulmonary Services
Peoria, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
Kentuckiana Pulmonary Associates
Louisville, Kentucky, United States
University of Louisville School of Medicine
Louisville, Kentucky, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
Maine Medical Center
Portland, Maine, United States
University of Maryland Medical Centre
Baltimore, Maryland, United States
Johns Hopkins University
Baltimore, Maryland, United States
University of Michigan Pulmonary Hypertension Program
Ann Arbor, Michigan, United States
Wayne State University, Detroit Medical Center
Detroit, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
William Beaumont Hospital - Troy
Troy, Michigan, United States
Nebraska Pulmonary Specialties, LLC
Lincoln, Nebraska, United States
Creighton University Medical Centre - Pulmonary, Critical Care and Sleep Medicine Division
Omaha, Nebraska, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
The Lung Center of Nevada
Las Vegas, Nevada, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Michael Schwarz, MDFACC
Bloomfield, New Jersey, United States
Respiratory Health & Critical Care Associates
Hawthorne, New Jersey, United States
Pulmonary Hypertension & Lung Transplant Program Newark Beth Israel Medical Center
Newark, New Jersey, United States
North Shore - LIJ Health System
New Hyde Park, New York, United States
Beth Israel Medical Center
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
East Carolina University
Greenville, North Carolina, United States
Wake Forest University Phyisicans Clinic/Pulmonary
Winston-Salem, North Carolina, United States
The Christ Hospital Heart & Vascular Center
Cincinnati, Ohio, United States
University of Cincinnati Pulmonary Critical Care & Sleep Medicine
Cincinnati, Ohio, United States
University Hospitals Case Medical Center
Cleveland, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Dayton Respiratory Center
Dayton, Ohio, United States
University of Toledo Health Sciences Campus
Toledo, Ohio, United States
Heart Center Cardiology
Bend, Oregon, United States
Central Bucks Specialists - The Pavilion at Doylestown Hospital
Doylestown, Pennsylvania, United States
Institute for Respiratory and Sleep Medicine
Langhorne, Pennsylvania, United States
Pulmonary Hypertension Program, Cardiology, Children's Hospial of Philadelphia
Philadelphia, Pennsylvania, United States
Pulmonary Vascular Disease Program, Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Respiratory Specialists
Wyomissing, Pennsylvania, United States
Wellspan Lung, Sleep and Critical Care
York, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Sioux Falls Cardiovascular PC
Sioux Falls, South Dakota, United States
Statcare Pulmonary Consultants
Knoxville, Tennessee, United States
El Paso Respiratory and Sleep Consultants
El Paso, Texas, United States
University of Texas Medical Branch
Galveston, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
UT Health - University of Texas Houston
Houston, Texas, United States
Providence Health Center
Waco, Texas, United States
IHVI, Advanced Lung Disease and Transplant Clinic
Falls Church, Virginia, United States
Sentara Medical Group
Norfolk, Virginia, United States
Cardiac Study Center
Puyallup, Washington, United States
PAH Clinic CPR at Auxilio Mutuo
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC-052-428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.